Bigfoot Biomedical has joined a rush of companies looking to launch the 'artificial pancreas' into mainstream type 1 diabetes treatment within the next few years.
Cancer Research UK (CRUK) has said it will award £123 million ($150 million) in funding over the next seven years to Scotland’s Beatson Institute, which will be renamed th
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho